TrialEuropean heart journal. Cardiovascular pharmacotherapy2024

Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trial.

Konstantin A Krychtiuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.